trial
as of 2026-07-01Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders
NCTId NCT01831986
at a glance
— · Unknown
Enrollment 60 (estimated)
Sponsored by Sha'ar Menashe Mental Health Center
Primary completion 2013-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2011-01
Primary completion
2013-12
Eligibility
ALL · 18 Years · 50 Years
Interventions & indications
Sponsors
Sha'ar Menashe Mental Health CenterLead Sponsor
Tirat Carmel Mental Health CenterCollaborator
Investigators
1
Michael S. Ritsner, MD, PhDPrincipal Investigator
Sites
0 total
Facts & assertions
4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2013-12
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator